$RGBP ~ Regen BioPharma Responds to FDA Comments on Its Application for Orphan Drug Designation on its Aplastic Anemia Therapy https://finance.yahoo.com/news/regen-biopharma-responds-fda-comments-120000009.html investorshub.advfn.com/uimage/uploads/2016/9/22/mkbmfname.PNG investorshub.advfn.com/uimage/uploads/2016/9/22/dnw[dpr.9.22.16.responds.fda.PNG #AMGN #BIIB #CELG #GILD #REGN #VRTX #MYL